Jefferies analyst Omar Nokta upgrades Frontline (NYSE:FRO) from Hold to Buy and raises the price target from $11 to $16.
Benzinga’s Top Ratings Upgrades, Downgrades For August 14, 2023
Upgrades According to Barrington Research, the prior rating for Anika Therapeutics Inc (NASDAQ:ANIK) was changed from Market Perform…